查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954058

日本准药品保养护肤市场规模、份额、趋势及预测（依皮肤状况、成分类型、应用、通路、产品特性及地区划分，2026-2034年）

Japan Medicated Skincare Market Size, Share, Trends and Forecast by Skin Condition, Ingredient Type, Application Type, Distribution Channel, Product Feature, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 5-7个工作天内

价格
简介目录

日本准药品护肤市场在2025年达到29.92亿美元。 IMARC集团预测，到2034年，该市场规模将达到61.58亿美元，2026年至2034年的复合年增长率（CAGR）为8.35%。这一市场成长主要受以下因素的协同效应驱动：・尖端皮肤病学的融合；・皮肤健康日益受到重视；・消费者对针对特定皮肤问题（如痤疮、色素沉着和敏感肌肤）的产品需求不断增长。此外，消费者对预防性护肤的意识增强、人口老化以及对经临床验证的高品质成分的认可，也推动了准药品护肤的流行。除了监管部门对准药品的支持外，国内外品牌基于创新和永续性的竞争也推动了日本准药品护肤市场份额的扩张。

日本准药品护肤市场趋势：

消费者信心与法规环境

日本的准药品护肤产业以厚生劳动省（MHLW）严格的法规环境为特征。宣称具有疗效的产品必须经过严格的核准程序，以确保其安全性和有效性。这种严格的监管有助于建立消费者信任，日本消费者往往认为「准药品」比一般化妆品更值得信赖。儘管有许多限制，但凭藉其安全性和品质方面的良好声誉，拥有强大研发能力的知名品牌依然蓬勃发展。因此，法规环境既保护了消费者权益，也有效阻止了假冒伪劣产品在市场上的氾滥。

科技与个性化的融合

日本准药妆护肤产业正积极拥抱更多科技进步，以满足消费者日益增长的个人化护肤产品需求。消费者对针对自身肌肤问题的客製化产品的需求，促使企业将人工智慧 (AI) 和物联网 (IoT) 技术融入产品之中。这些技术能够根据特定的肌肤分析结果，打造出个人化的护肤方案，进而提升产品功效和顾客满意度。此外，家用诊断设备和虚拟护肤课程等美容科技设备的出现，正在重塑消费者的护肤体验，带来更具互动性和个人化的护肤流程。这种技术融合不仅满足了消费者的需求，也使企业在护肤产业的创新中处于领先地位，进一步推动了日本准药护肤市场的成长。

注重永续性和道德实践

在消费者日益关注环境和伦理因素的推动下，永续性已成为日本准药护肤产业的一大趋势。日本消费者越来越倾向选择未经动物测试、采用可回收包装且原料来源符合伦理的产品。为此，护肤品牌积极实践绿色美容概念，例如开发可重复填充包装、使用植物来源成分以及减少塑胶废弃物。这种向永续性的转变与全球环境目标以及日本消费者重视地球健康的价值观相契合。因此，致力于永续性的企业能够在市场竞争中获得优势，并吸引更多具有环保意识的消费者。

本报告解答的关键问题

  • 日本准药品护肤市场目前发展状况如何？您认为未来几年它将如何发展？
  • 日本准药品护肤市场如何根据肌肤状况进行细分？
  • 日本准药品护肤市场以成分类型分類的市场构成为何？
  • 日本准药品护肤市场按应用领域分類的细分情况如何？
  • 日本准药品护肤市场依通路分類的情况如何？
  • 根据产品特性，日本准药品护肤市场的市场区隔如何？
  • 日本准药品护肤市场按地区分類的情况如何？
  • 请介绍日本准药品护肤市场价值链的各个环节。
  • 日本准药品护肤市场的主要驱动因素和挑战是什么？
  • 日本准药品护肤市场的结构是怎么样的？主要参与者有哪些？
  • 日本准药品护肤市场的竞争程度如何？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章：日本准药品护肤市场概览

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章：日本准药品护肤市场：现状

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本准药品保养护肤市场－依皮肤状况细分

  • 粉刺
  • 湿疹
  • 银屑病
  • 酒糟
  • 色素沉着

第七章：日本准药品保养护肤市场－依成分类型细分

  • 抗发炎药
  • 抗菌剂
  • 抗真菌剂
  • 抗氧化剂
  • 保湿霜

第八章：日本准药品护肤市场－依应用领域细分

  • 奶油
  • 洗剂
  • 软膏
  • 凝胶
  • 美容精华液

第九章：日本准药品保养护肤市场－依销售管道细分

  • 非处方药
  • 处方笺
  • 线上零售
  • 药局
  • 皮肤科诊所

第十章：日本准药品保养护肤市场－依产品特性细分

  • 低过敏性
  • 不致粉刺
  • 无香型
  • 不含对羟基苯甲酸酯
  • 无动物实验产品

第十一章：日本准药品护肤市场：依地区划分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十二章：日本准药品护肤市场的竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十三章主要企业概况

第十四章：日本准药品保养护肤市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十五章附录

简介目录
Product Code: SR112026A36778

The Japan medicated skincare market size reached USD 2,992.0 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 6,158.0 Million by 2034 , exhibiting a growth rate (CAGR) of 8.35% during 2026-2034 . The market is driven primarily by the synergistic mix of cutting-edge dermatological science, vast cultural significance assigned to skin health, and increasing consumer demand for products addressing certain skin conditions such as acne, hyperpigmentation, and sensitivity. Increasing awareness about preventive skincare, aging population, and acceptance of high-quality clinically proven ingredients have also fortified the popularity of medicated skincare. Regulatory assistance to quasi-drugs, along with competition based on innovation and sustainability from locally and globally available brands are fueling the Japan medicated skincare market share.

JAPAN MEDICATED SKINCARE MARKET TRENDS:

Consumer Confidence and Regulatory Environment

Japan's medicated skincare industry is characterized by its strict regulatory environment, which is governed by the Ministry of Health, Labour and Welfare (MHLW). The products that make therapeutic claims need to go through intense approval procedures, assuring safety and effectiveness. This regulatory stringency encourages consumer confidence, whereby Japanese consumers tend to find "quasi-drugs" more trustworthy than regular cosmetics. Notwithstanding restrictions, well-established brands with strong research and development functions still flourish, based on their brand reputation for safety and quality. The regulatory environment is therefore both a protection for consumers and a barrier to expansion for false products in the market.

Integration of Technology and Personalization

The Japanese medicated skincare industry is moving toward adopting more technological advances to address the increasing need for customized skincare products. The consumers are demanding products suited to their individual skin issues, driving companies to incorporate artificial intelligence (AI) and Internet of Things (IoT) based technologies into products. These technologies allow for the formulation of personalized skincare routines based on specific skin analyses, improving product performance and customer satisfaction. Moreover, the emergence of beauty tech devices, including at-home diagnostic machines and virtual skincare sessions, is rewriting the consumer experience, enhancing skincare routines by making them more interactive and customized. This technological integration satisfies consumer demands and places companies at the cusp of innovation in the world of skincare, which further propels the Japan medicated skincare market growth.

Focus on Sustainability and Ethical Practices

Sustainability is now a key trend in Japan's medicated skincare industry, due to enhanced consumer concern regarding environmental and ethical factors. Consumers in Japan are gravitating toward products that are cruelty-free, employ recyclable packaging, and are made through ethical means of procurement. Skincare brands are embracing green beauty practices in return, such as creating refillable packaging, making use of plant-based ingredients, and reducing plastic waste. This transition toward sustainability is congruent with worldwide environmental objectives while it also coincides with Japanese consumers' values of placing importance on the health of the planet. Consequently, companies that take the commitment to sustainability gain a competitive advantage over others in the marketplace, and attract more environmentally aware consumers.

JAPAN MEDICATED SKINCARE MARKET SEGMENTATION:

Skin Condition Insights:

  • Acne
  • Eczema
  • Psoriasis
  • Rosacea
  • Hyperpigmentation

Ingredient Type Insights:

  • Anti-Inflammatories
  • Antibacterials
  • Antifungals
  • Antioxidants
  • Moisturizers

Application Type Insights:

  • Creams
  • Lotions
  • Ointments
  • Gels
  • Serums

Distribution Channel Insights:

  • Over-The-Counter
  • Prescription
  • Online Retail
  • Pharmacy
  • Dermatologist Clinic

Product Feature Insights:

  • Hypoallergenic
  • Non-Comedogenic
  • Fragrance-Free
  • Paraben-Free
  • Cruelty-Free

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central /Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central /Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan medicated skincare market performed so far and how will it perform in the coming years?
  • What is the breakup of the Japan medicated skincare market on the basis of skin condition?
  • What is the breakup of the Japan medicated skincare market on the basis of ingredient type?
  • What is the breakup of the Japan medicated skincare market on the basis of application type?
  • What is the breakup of the Japan medicated skincare market on the basis of distribution channel?
  • What is the breakup of the Japan medicated skincare market on the basis of product feature?
  • What is the breakup of the Japan medicated skincare market on the basis of region?
  • What are the various stages in the value chain of the Japan medicated skincare market?
  • What are the key driving factors and challenges in the Japan medicated skincare market?
  • What is the structure of the Japan medicated skincare market and who are the key players?
  • What is the degree of competition in the Japan medicated skincare market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Medicated Skincare Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Medicated Skincare Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Medicated Skincare Market - Breakup by Skin Condition

  • 6.1 Acne
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Eczema
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Psoriasis
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Rosacea
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Hyperpigmentation
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Forecast (2026-2034)

7 Japan Medicated Skincare Market - Breakup by Ingredient Type

  • 7.1 Anti-Inflammatories
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Antibacterials
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Antifungals
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Antioxidants
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Moisturizers
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)

8 Japan Medicated Skincare Market - Breakup by Application Type

  • 8.1 Creams
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Lotions
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Ointments
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Gels
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Forecast (2026-2034)
  • 8.5 Serums
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2020-2025)
    • 8.5.3 Market Forecast (2026-2034)

9 Japan Medicated Skincare Market - Breakup by Distribution Channel

  • 9.1 Over-The-Counter
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Prescription
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)
  • 9.3 Online Retail
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Forecast (2026-2034)
  • 9.4 Pharmacy
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Forecast (2026-2034)
  • 9.5 Dermatologist Clinic
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Forecast (2026-2034)

10 Japan Medicated Skincare Market - Breakup by Product Feature

  • 10.1 Hypoallergenic
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Forecast (2026-2034)
  • 10.2 Non-Comedogenic
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Forecast (2026-2034)
  • 10.3 Fragrance-Free
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Forecast (2026-2034)
  • 10.4 Paraben-Free
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2020-2025)
    • 10.4.3 Market Forecast (2026-2034)
  • 10.5 Cruelty-Free
    • 10.5.1 Overview
    • 10.5.2 Historical and Current Market Trends (2020-2025)
    • 10.5.3 Market Forecast (2026-2034)

11 Japan Medicated Skincare Market - Breakup by Region

  • 11.1 Kanto Region
    • 11.1.1 Overview
    • 11.1.2 Historical and Current Market Trends (2020-2025)
    • 11.1.3 Market Breakup by Skin Condition
    • 11.1.4 Market Breakup by Ingredient Type
    • 11.1.5 Market Breakup by Application Type
    • 11.1.6 Market Breakup by Distribution Channel
    • 11.1.7 Market Breakup by Product Feature
    • 11.1.8 Key Players
    • 11.1.9 Market Forecast (2026-2034)
  • 11.2 Kansai/Kinki Region
    • 11.2.1 Overview
    • 11.2.2 Historical and Current Market Trends (2020-2025)
    • 11.2.3 Market Breakup by Skin Condition
    • 11.2.4 Market Breakup by Ingredient Type
    • 11.2.5 Market Breakup by Application Type
    • 11.2.6 Market Breakup by Distribution Channel
    • 11.2.7 Market Breakup by Product Feature
    • 11.2.8 Key Players
    • 11.2.9 Market Forecast (2026-2034)
  • 11.3 Central/ Chubu Region
    • 11.3.1 Overview
    • 11.3.2 Historical and Current Market Trends (2020-2025)
    • 11.3.3 Market Breakup by Skin Condition
    • 11.3.4 Market Breakup by Ingredient Type
    • 11.3.5 Market Breakup by Application Type
    • 11.3.6 Market Breakup by Distribution Channel
    • 11.3.7 Market Breakup by Product Feature
    • 11.3.8 Key Players
    • 11.3.9 Market Forecast (2026-2034)
  • 11.4 Kyushu-Okinawa Region
    • 11.4.1 Overview
    • 11.4.2 Historical and Current Market Trends (2020-2025)
    • 11.4.3 Market Breakup by Skin Condition
    • 11.4.4 Market Breakup by Ingredient Type
    • 11.4.5 Market Breakup by Application Type
    • 11.4.6 Market Breakup by Distribution Channel
    • 11.4.7 Market Breakup by Product Feature
    • 11.4.8 Key Players
    • 11.4.9 Market Forecast (2026-2034)
  • 11.5 Tohoku Region
    • 11.5.1 Overview
    • 11.5.2 Historical and Current Market Trends (2020-2025)
    • 11.5.3 Market Breakup by Skin Condition
    • 11.5.4 Market Breakup by Ingredient Type
    • 11.5.5 Market Breakup by Application Type
    • 11.5.6 Market Breakup by Distribution Channel
    • 11.5.7 Market Breakup by Product Feature
    • 11.5.8 Key Players
    • 11.5.9 Market Forecast (2026-2034)
  • 11.6 Chugoku Region
    • 11.6.1 Overview
    • 11.6.2 Historical and Current Market Trends (2020-2025)
    • 11.6.3 Market Breakup by Skin Condition
    • 11.6.4 Market Breakup by Ingredient Type
    • 11.6.5 Market Breakup by Application Type
    • 11.6.6 Market Breakup by Distribution Channel
    • 11.6.7 Market Breakup by Product Feature
    • 11.6.8 Key Players
    • 11.6.9 Market Forecast (2026-2034)
  • 11.7 Hokkaido Region
    • 11.7.1 Overview
    • 11.7.2 Historical and Current Market Trends (2020-2025)
    • 11.7.3 Market Breakup by Skin Condition
    • 11.7.4 Market Breakup by Ingredient Type
    • 11.7.5 Market Breakup by Application Type
    • 11.7.6 Market Breakup by Distribution Channel
    • 11.7.7 Market Breakup by Product Feature
    • 11.7.8 Key Players
    • 11.7.9 Market Forecast (2026-2034)
  • 11.8 Shikoku Region
    • 11.8.1 Overview
    • 11.8.2 Historical and Current Market Trends (2020-2025)
    • 11.8.3 Market Breakup by Skin Condition
    • 11.8.4 Market Breakup by Ingredient Type
    • 11.8.5 Market Breakup by Application Type
    • 11.8.6 Market Breakup by Distribution Channel
    • 11.8.7 Market Breakup by Product Feature
    • 11.8.8 Key Players
    • 11.8.9 Market Forecast (2026-2034)

12 Japan Medicated Skincare Market - Competitive Landscape

  • 12.1 Overview
  • 12.2 Market Structure
  • 12.3 Market Player Positioning
  • 12.4 Top Winning Strategies
  • 12.5 Competitive Dashboard
  • 12.6 Company Evaluation Quadrant

13 Profiles of Key Players

  • 13.1 Company A
    • 13.1.1 Business Overview
    • 13.1.2 Products Offered
    • 13.1.3 Business Strategies
    • 13.1.4 SWOT Analysis
    • 13.1.5 Major News and Events
  • 13.2 Company B
    • 13.2.1 Business Overview
    • 13.2.2 Products Offered
    • 13.2.3 Business Strategies
    • 13.2.4 SWOT Analysis
    • 13.2.5 Major News and Events
  • 13.3 Company C
    • 13.3.1 Business Overview
    • 13.3.2 Products Offered
    • 13.3.3 Business Strategies
    • 13.3.4 SWOT Analysis
    • 13.3.5 Major News and Events
  • 13.4 Company D
    • 13.4.1 Business Overview
    • 13.4.2 Products Offered
    • 13.4.3 Business Strategies
    • 13.4.4 SWOT Analysis
    • 13.4.5 Major News and Events
  • 13.5 Company E
    • 13.5.1 Business Overview
    • 13.5.2 Products Offered
    • 13.5.3 Business Strategies
    • 13.5.4 SWOT Analysis
    • 13.5.5 Major News and Events

14 Japan Medicated Skincare Market - Industry Analysis

  • 14.1 Drivers, Restraints, and Opportunities
    • 14.1.1 Overview
    • 14.1.2 Drivers
    • 14.1.3 Restraints
    • 14.1.4 Opportunities
  • 14.2 Porters Five Forces Analysis
    • 14.2.1 Overview
    • 14.2.2 Bargaining Power of Buyers
    • 14.2.3 Bargaining Power of Suppliers
    • 14.2.4 Degree of Competition
    • 14.2.5 Threat of New Entrants
    • 14.2.6 Threat of Substitutes
  • 14.3 Value Chain Analysis

15 Appendix